🔴 Icecure Medical is trading 10% down in pre-market — no company-specific catalyst confirmed

Icecure Medical is trading 10.32% down at $2.18, with no direct company-specific catalyst confirmed for August 24, 2026.

• The decline extends a seven-session slide from $3.00 on August 13 to $2.43 on August 21.
• Recent pressure may reflect lingering concern after the August 12 report, which showed second-quarter revenue below analyst expectations and a wider-than-expected adjusted loss.
• That earlier earnings disappointment does not establish a direct cause for the August 24 pre-market move.